TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD

QQQ $ 476.27 $ 0.61 (0.13 %)

DIA $ 408.74 $ 1.31 (0.32 %)

SPY $ 556.44 $ 1.55 (0.28 %)

TLT $ 97.81 $ -0.13 (-0.13 %)

GLD $ 231.38 $ 1.18 (0.51 %)

Previous Close

$ 18.26

Open

$ 18.17

Bid

$ 18.06 x 300

Ask

$ 18.07 x 500

Day's Range

$ 17.87 - $ 18.21

52 Week Range

$ 8.06 - $ 18.58

Volume

5,640,279

Average Volume

Market Cap

20.69B

Beta (5Y Monthly)

$ 1.13

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-12-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	02-10-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	07-27-2022	06-30-2022	10-Q
10	05-03-2022	03-31-2022	10-Q
11	02-09-2022	12-31-2021	10-K
12	10-27-2021	09-30-2021	10-Q
13	07-28-2021	06-30-2021	10-Q
14	04-28-2021	03-31-2021	10-Q
15	02-10-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	02-21-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-02-2019	03-31-2019	10-Q
23	02-19-2019	12-31-2018	10-K
24	11-01-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-03-2018	03-31-2018	10-Q
27	02-12-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

100-invested-in-teva-pharmaceutical-indus-5-years-ago-would-be-worth-this-much-today

$100 Invested In Teva Pharmaceutical Indus...
08/13/2024 21:01:23

Barclays Maintains Overweight on Teva Phar...
08/01/2024 16:50:17

Barclays analyst Balaji Prasad maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target...

tech-stocks-on-track-for-best-session-in-5-months-ahead-of-fed-meeting-small-caps-target-highest-close-since-january-2022-whats-driving-markets-wednesday

Tech Stocks On Track For Best Session In 5...
07/31/2024 17:23:22

Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Commi...

match-group-posts-upbeat-sales-joins-modine-manufacturing-scotts-miracle-gro-nvidia--and-other-big-stocks-moving-higher-on-wednesday

Match Group Posts Upbeat Sales, Joins Modi...
07/31/2024 17:05:44

teva-beats-q2-estimates-raises-annual-outlook-on-strong-generic-austedo-sales

Teva Beats Q2 Estimates, Raises Annual Out...
07/31/2024 14:38:14

Teva Pharmaceutical reported Q2 2024 sales of $4.16 billion, surpassing the $4.06 billion consensus. Revenue rose 7% YoY, drive...

wall-street-remains-on-track-for-amd-led-rebound-ahead-of-fed-decision-meta-earnings-analyst-says-the-bull-tends-to-remain-despite-near-term-volatility

Wall Street Remains On Track For AMD-Led R...
07/31/2024 11:55:46

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro ...

Teva Pharmaceutical Expects 2024 Adjusted ...
07/31/2024 11:08:02

Teva Pharmaceutical Expects 2024 Revenues ...
07/31/2024 11:06:20

Outlook for 2024 Non-GAAP Results $ billions, except EPS or as noted July 2024 Outlook January 2024 Outlook ...

Teva Pharmaceutical Indus Q2 2024 Adj. EPS...
07/31/2024 11:01:42

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
07/30/2024 17:35:22

apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings

Apple, Amazon, Microsoft, Meta Lead The Ch...
07/29/2024 10:25:11

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

Teva And Sanofi Fast-Track Anti-TL1A Phase...
07/25/2024 05:47:08

Enrollment acceleration drives earlier-than-anticipated data availability for this potentially best-in-class IBD treatment T...

why-hims--hers-heath-shares-are-surging-today

Why Hims & Hers Heath Shares Are Surging T...
07/22/2024 19:23:33

Hims & Hers Health Inc. (NYSE: HIMS) shares are moving higher on Monday amidst the announcement of Kåre Schultz's appoi...

100-invested-in-this-stock-5-years-ago-would-be-worth-200-today

$100 Invested In This Stock 5 Years Ago Wo...
07/19/2024 18:30:27

tevas-migraine-treatment-found-effective-for-children-as-young-as-6

Teva's Migraine Treatment Found Effective ...
07/18/2024 16:06:36

Teva Pharmaceutical's Phase 3 SPACE study reveals Ajovy's significant efficacy in preventing episodic migraines in chil...

Teva SPACE Pediatric Phase 3 Study Met Its...
07/18/2024 12:36:13

SPACE pediatric Phase 3 study met its primary end point for efficacy with a significantly greater reduction in Monthly Migraine...

jim-cramer-says-dont-sell-match-group-youve-just-got-a-very-very-smart-investor-in-there

Jim Cramer Says Don't Sell Match Group: 'Y...
07/17/2024 12:55:11

Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run c...

heres-how-much-1000-invested-in-teva-pharmaceutical-indus-5-years-ago-would-be-worth-today

Here's How Much $1000 Invested In Teva Pha...
07/16/2024 16:03:59

MediWound Files Amendment To Settlement Ag...
07/15/2024 20:13:08

- SEC Filing

UBS Maintains Buy on Teva Pharmaceutical I...
07/11/2024 02:11:40

UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price target from $22 to...